1. Home >
  2. M&A >
  3. Growth Capital >
  4. Italy >
  5. Trilantic Europe Invests In ICS Maugeri

Investment Summary

Trilantic Europe Invests In ICS Maugeri

On February 24, 2016, private equity firm Trilantic Europe invested in healthcare services company ICS Maugeri

Investment Highlights
  • This is Trilantic Europe’s 1st transaction in the Healthcare Services sector.
  • This is Trilantic Europe’s 5th transaction in Italy.

Investment Summary
Date 2016-02-24
Target ICS Maugeri
Sector Healthcare Services
Investor(s) Trilantic Europe
Deal Type Growth Capital

Target

ICS Maugeri

Pavia, Italy
ICS Maugeri is an Italian operator of private hospitals, specialised in post-acute rehabilitation treatments. The company operates 2,400 beds in 18 hospitals, of which 10 are research hospitals (IRCCS). It employs approx. 650 doctors and researchers. ICS Maugeri is a spin-out of Fondazione Salvatore Maugeri, established in 1965 to focus on safety and health risks in the working environment. ICS Maugeri is the Italian leader in pneumology, neuromotor and cardiologic rehabilitation, with a particular focus on chronic diseases. ICS Maugeri is based in Pavia, Italy.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Trilantic Europe

Category Private Equity Firm
PE ASSETS 2.3B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Trilantic Europe is a private equity firm focused on buyouts and consolidation opportunities of mid-market companies across Western Europe. The Firm focuses on control or co-control situations where it can act as a hands-on investor pursuing growth opportunities and strategies. Sectors of interest include consumer, leisure, industrials, technology, media, communications, business services, and healthcare. The Firm is associated with Trilantic North America and originated from Lehman Brother's merchant banking division in 2009. Trilantic Europe is headquartered in London, England.

DEAL STATS #
Overall 14 of 26
Sector: Healthcare Services M&A 1 of 4
Type: Growth Capital M&A Deals 1 of 3
Country: Italy M&A 5 of 8
Year: 2016 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-13 Doppel

Cortemaggiore, Italy

Doppel is an operator in Italy in pharmaceutical research, development, formulation, manufacturing and packaging. The company operates exclusively on behalf of third parties as a Contract Development and Manufacturing Organization (CDMO). Doppel manufactures and packages mainly solid pharmaceutical oral dosage forms, solid parenterals, high activity solids, semi-solids and liquids, and effervescent alimentary granules. Doppel’s customers are branded and generic pharma companies. Doppel is also active in the nutraceuticals market by manufacturing probiotic-based nutritional supplements in powder and granules. Doppel was founded in 1994 and is based in Cortemaggiore, Italy.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-04-07 Pacha

Ibiza, Spain

Pacha is a leisure, hospitality and entertainment group. The Group is currently active in night clubs, hotels, restaurants, magazines, event organisation, franchises, music production and clothing and accessories stores. Pacha was founded in 1967 and is based in Ibiza, Spain.

Buy -
Mergr

Solution for

Product

Company

Legal